Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oncology Institute (TOI) Net Income (2020 - 2025)

Oncology Institute's Net Income history spans 6 years, with the latest figure at -$7.5 million for Q4 2025.

  • For Q4 2025, Net Income rose 43.04% year-over-year to -$7.5 million; the TTM value through Dec 2025 reached -$60.6 million, up 6.27%, while the annual FY2025 figure was -$60.6 million, 6.27% up from the prior year.
  • Net Income reached -$7.5 million in Q4 2025 per TOI's latest filing, up from -$16.5 million in the prior quarter.
  • In the past five years, Net Income ranged from a high of $19.3 million in Q1 2022 to a low of -$30.0 million in Q1 2023.
  • Average Net Income over 5 years is -$11.0 million, with a median of -$14.3 million recorded in 2024.
  • Peak YoY movement for Net Income: skyrocketed 2036.35% in 2022, then plummeted 551.42% in 2023.
  • A 5-year view of Net Income shows it stood at -$10.2 million in 2021, then decreased by 8.38% to -$11.0 million in 2022, then plummeted by 70.38% to -$18.8 million in 2023, then grew by 29.71% to -$13.2 million in 2024, then soared by 43.04% to -$7.5 million in 2025.
  • Per Business Quant, the three most recent readings for TOI's Net Income are -$7.5 million (Q4 2025), -$16.5 million (Q3 2025), and -$17.0 million (Q2 2025).